|
Volumn 98, Issue 2, 2014, Pages 541-547
|
Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: The duraheart trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN;
LACTATE DEHYDROGENASE;
ADULT;
AGED;
ARTICLE;
BODY SURFACE;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
DEEP VEIN THROMBOSIS;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL HEMORRHAGE;
HEART ARRHYTHMIA;
HEART FAILURE;
HEART RIGHT VENTRICLE FAILURE;
HEART SUPRAVENTRICULAR ARRHYTHMIA;
HEART VENTRICLE ARRHYTHMIA;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
INFECTION;
KIDNEY DYSFUNCTION;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LEFT VENTRICULAR ASSIST DEVICE;
LIVER DYSFUNCTION;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DEVICE COMPLICATION;
METABOLIC ENCEPHALOPATHY;
MULTICENTER STUDY;
OBSERVATIONAL STUDY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PUMP THROMBUS;
QUALITY OF LIFE;
RESPIRATORY FAILURE;
SEPSIS;
SURVIVAL;
THROMBOSIS;
TRANSIENT ISCHEMIC ATTACK;
ADULT;
AGED;
FEMALE;
HEART FAILURE;
HEART-ASSIST DEVICES;
HUMANS;
MAGNETIC PHENOMENA;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
PROSTHESIS DESIGN;
YOUNG ADULT;
|
EID: 84905589169
PISSN: 00034975
EISSN: 15526259
Source Type: Journal
DOI: 10.1016/j.athoracsur.2014.04.048 Document Type: Article |
Times cited : (21)
|
References (8)
|